Drug Shortage Report for APO-SITAGLIPTIN/METFORMIN XR
| Report ID | 185982 |
| Drug Identification Number | 02506289 |
| Brand name | APO-SITAGLIPTIN/METFORMIN XR |
| Common or Proper name | SITAGLIPTAN PHOSPHATE/METFORMIN |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | METFORMIN HYDROCHLORIDE SITAGLIPTIN |
| Strength(s) | 1000MG 50MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 500 BTL |
| ATC code | A10BD |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-03-02 |
| Estimated end date | 2024-01-31 |
| Actual end date | 2024-02-01 |
| Shortage status | Resolved |
| Updated date | 2024-02-02 |
| Company comments | Product on allocation due to increased demand |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.